- Home
- BDSX vs EMX Comparison
BDSX vs EMX Comparison
Compare BDSX & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- EMX
- Stock Information
- Founded
- BDSX 2005
- EMX N/A
- Country
- BDSX United States
- EMX Canada
- Employees
- BDSX N/A
- EMX N/A
- Industry
- BDSX Precision Instruments
- EMX
- Sector
- BDSX Health Care
- EMX
- Exchange
- BDSX Nasdaq
- EMX Nasdaq
- Market Cap
- BDSX 215.3M
- EMX 202.9M
- IPO Year
- BDSX 2020
- EMX N/A
- Fundamental
- Price
- BDSX $0.88
- EMX $1.81
- Analyst Decision
- BDSX Strong Buy
- EMX Strong Buy
- Analyst Count
- BDSX 4
- EMX 1
- Target Price
- BDSX $3.08
- EMX $7.00
- AVG Volume (30 Days)
- BDSX 359.8K
- EMX 323.6K
- Earning Date
- BDSX 03-03-2025
- EMX 03-24-2025
- Dividend Yield
- BDSX N/A
- EMX N/A
- EPS Growth
- BDSX N/A
- EMX N/A
- EPS
- BDSX N/A
- EMX N/A
- Revenue
- BDSX $65,562,000.00
- EMX $26,818,000.00
- Revenue This Year
- BDSX $46.97
- EMX N/A
- Revenue Next Year
- BDSX $31.65
- EMX $2.34
- P/E Ratio
- BDSX N/A
- EMX N/A
- Revenue Growth
- BDSX 48.92
- EMX 25.53
- 52 Week Low
- BDSX $0.86
- EMX $1.47
- 52 Week High
- BDSX $2.04
- EMX $2.15
- Technical
- Relative Strength Index (RSI)
- BDSX 30.29
- EMX 51.89
- Support Level
- BDSX $0.90
- EMX $1.72
- Resistance Level
- BDSX $1.00
- EMX $1.91
- Average True Range (ATR)
- BDSX 0.07
- EMX 0.06
- MACD
- BDSX 0.00
- EMX -0.00
- Stochastic Oscillator
- BDSX 3.41
- EMX 47.37
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco, and Australia.